Home   >  
Angiogenesis/Protein Tyrosine Kinase

Classified by application

All Products

Signaling Pathways

Research Areas

Nature products






Raw Materials


Chemical Structure Cat. No. Product Name CAS No.
Certepetide Chemical Structure
BCP49241 Certepetide 2580154-02-3
Certepetide is a bifunctional cyclic peptide (a.k.a. iRGD).
Bexotegrast Chemical Structure
BCP49211 Bexotegrast 2376257-44-0
Bexotegrast is a potent inhibitor of ανβ6 integrin. Bexotegrast can be used for researching fibrosis such as idiopathic pulmonary fibrosis (IPF) and nonspecific interstitial pneumonia (NSIP).
Alintegimod Chemical Structure
BCP49203 Alintegimod 1378535-08-0
Alintegimod, also known as 7HP349, has the potential to offer a novel mechanism to safely overcome resistance to a broad range of immunotherapies, including anti-tumor immune checkpoint inhibitors and infectious disease vaccines.
PLN-1474 Chemical Structure
BCP47995 PLN-1474 2408065-32-5
PLN-1474 is a small molecule, orally available, selective inhibitor of integrin alphaVbeta1 (αVβ1).
Glycyl-arginyl-glycyl-aspartyl-seryl-proline Chemical Structure
BCP45564 Glycyl-arginyl-glycyl-aspartyl-seryl-proline 91037-75-1
GRGDSP, a synthetic linear RGD peptide, is an integrin inhibitor which can be used to modify the surface of cardiovascular implants such as vascular grafts to promote endothelialization.
Carotegrast Chemical Structure
BCP40366 Carotegrast 401904-75-4
Carotegrast is an anti-inflammatory agent.
Carotegrast methyl Chemical Structure
BCP40218 Carotegrast methyl 401905-67-7
Carotegrast methyl is an orally-active small molecule that antagonises the α4 integrin receptor.
A 286982 Chemical Structure
BCP37784 A 286982 280749-17-9
A 286982 is a potent inhibitor of the LFA-1/ICAM-1 interaction (IC50 = 44 and 35 nM in LFA-1/ICAM-1 binding and LFA-1-mediated cell adhesion assays, respectively).
QLT0267 Chemical Structure
BCP25954 QLT0267 866409-68-9
QLT0267 is an ATP-competitive selective inhibitor of integrin-linked kinase (ILK).
Vedolizumab Chemical Structure
BCP26256 Vedolizumab 943609-66-3
Vedolizumab is a humanized monoclonal antibody that targets the α4β7 integrin for the treatment of ulcerative colitis and Crohn's disease.
123下一页末页共 34 条记录 1 / 4 页